A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for Hepatocellular Carcinoma
21 locations incl. Birmingham
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All·Age: 18+
Code: NCT05440708·Phase 1, Phase 2·Recruiting